|
Volumn 22, Issue 13, 2008, Pages
|
Small-cell lung cancer: Translational research enroute to therapeutic advances
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMRUBICIN;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CISPLATIN;
CYCLOPAMINE;
ETOPOSIDE;
GDC 0449;
IRINOTECAN;
PEMETREXED;
PLATINUM COMPLEX;
PROTEIN BCL 2;
SONIC HEDGEHOG PROTEIN;
STEM CELL FACTOR RECEPTOR;
THALIDOMIDE;
TOPOTECAN;
UNCLASSIFIED DRUG;
UROKINASE RECEPTOR;
ANTINEOPLASTIC ACTIVITY;
BRAIN METASTASIS;
CANCER INHIBITION;
CANCER RADIOTHERAPY;
CANCER RESISTANCE;
CANCER STAGING;
CANCER STEM CELL;
CANCER SURVIVAL;
CLINICAL TRIAL;
HUMAN;
LUNG SMALL CELL CANCER;
NONHUMAN;
PROTEIN EXPRESSION;
REVIEW;
SIGNAL TRANSDUCTION;
SKULL IRRADIATION;
ANTINEOPLASTIC AGENTS;
CARCINOMA, SMALL CELL;
HUMANS;
LUNG NEOPLASMS;
NEOPLASM STAGING;
SIGNAL TRANSDUCTION;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 58049083778
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (6)
|